Delivery Order SPE2DB22D3009-SPE2DB25FBB65
- Not listed
- The Defense Logistics Agency awarded a $1,930.67 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Kerendia 10 mg tablets (30-count units). This firm fixed-price delivery order, valued at $15,382.34, was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at the vendor's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,302.03 firm-fixed-price delivery order is for the supply of 4,565,600,616 units of the pharmaceutical product KERENDIA 10 MG TABLET 90S. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,003.64, is a delivery order for the pharmaceutical product "KERENDIA 20 MG TABLET 90S". The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) awarded a $3,982.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count) with an ultimate completion date of August 4, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems and is...
- This federal contract award, valued at $35,954.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of the medication KERENDIA 20 MG TABLET 90S, with a performance period ending on May 12, 2025. The contract is a firm-fixed-price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) with a ceiling value of $2,330.76. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- This federal contract award is for the delivery of the pharmaceutical product KERENDIA 10 MG TABLET 90S to the Defense Logistics Agency (DLA). The $4,859.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KERENDIA 10 MG TABLET 30S. The contract has a ceiling value of $5,107.73 and a period of performance through June 6, 2025. AmerisourceBergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania that is a critical supplier of medical and pharmaceutical products to federal agencies, including...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,536.04 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBB65Delivery Order
AmerisourceBergen Drug Corp was awarded a $2,376.01 firm fixed-price delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a non-set-aside competitive award with a completion date of July 23, 2025. The contract is performed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for the Defense Logistics Agency's Medical Supply Chain, supplying medications and medical commodities to support military and veteran healthcare systems globally. The company's extensive federal contract portfolio demonstrates its capacity to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains through open competition. The DLA Troop Support Medical contract vehicle enables the company to supply specialty medications, brand-name and generic drugs, vaccines, and other medical supplies to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/22/25 |